文献速递眼底病与葡萄膜炎

光动力疗法治疗中心性浆液性脉络膜视网膜病变中有症状的亚中心凹视网膜色素上皮脱离:结局与预后因素

PHOTODYNAMIC THERAPY FOR SYMPTOMATIC SUBFOVEAL RETINAL PIGMENT EPITHELIAL DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: Outcomes and Prognostic Factors.
PubMed 文献 · Retina · 2019-01-01

这项回顾性干预研究纳入35例(35眼)伴有脉络膜高通透性的浆液性亚中心凹视网膜色素上皮脱离(RPED)患者,均接受减低能量光动力疗法(PDT)。治疗后1个月80.0%的患眼RPED完全消退,最佳矫正视力从基线0.15(20/28)改善至治疗后3个月0.09(20/25)(P=0.008);年龄较大和RPED高度增加是RPED消退不良的独立危险因素。

要点

  • 减低能量PDT后1个月,28眼(80.0%)亚中心凹RPED完全消退。
  • 基线存在视物变形是主观视力改善的显著相关因素。
  • 年龄较大和RPED高度增加是RPED消退不良的独立危险因素。

核心结论

  • 中心性浆液性脉络膜视网膜病变中的亚中心凹RPED对减低能量PDT反应良好,尤其是在RPED较少的年轻患者中。
  • 视物变形而非视力下降是亚中心凹RPED的主要症状表现。

研究设计与样本

  • 回顾性干预研究,纳入35例患者的35眼伴有脉络膜高通透性的浆液性亚中心凹RPED,排除有年龄相关性黄斑变性证据的病例,每例患者均接受减低能量PDT。
  • 分析最佳矫正视力、RPED解剖学消退、主观症状改善和并发症。

主要发现

  • 减低能量PDT后1个月,28眼(80.0%)亚中心凹RPED完全消退。
  • 在RPED完全消退的患者中,19眼(67.9%)报告主观视力改善,该主观改善与基线存在视物变形显著相关。
  • 最小分辨角对数视力从基线0.15(Snellen等效20/28)改善至PDT后3个月0.09(20/25)(P=0.008)。
  • 年龄较大和RPED高度增加是PDT后RPED消退不良的独立危险因素。
  • 治疗后平均随访10.4±13.6个月,未发生RPED复发。

关键数值与推荐

  • 减低能量PDT后1个月RPED完全消退率为80.0%(28/35眼)。
  • RPED完全消退者中主观视力改善比例为67.9%(19/28眼)。
  • 最小分辨角对数视力从基线0.15(20/28)改善至PDT后3个月0.09(20/25),P=0.008。
  • 平均随访10.4±13.6个月,RPED复发0例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report the clinical outcomes of reduced-fluence photodynamic therapy (PDT) for symptomatic subfoveal retinal pigment epithelial detachment (RPED) in central serous chorioretinopathy and identify prognostic factors affecting treatment outcome. METHODS: This retrospective interventional study included 35 eyes of 35 patients with serous subfoveal RPED with choroidal hyperpermeability. Cases with evidence of age-related macular degeneration were excluded from the study. Reduced-fluence PDT was applied to each patient. Best-corrected visual acuity, anatomical resolution of RPED, subjective symptom improvement, and complications were analyzed. RESULTS: One month after reduced-fluence PDT, 28 eyes (80.0%) manifested complete resolution of subfoveal RPED. Among the patients whose eyes manifested complete resolution, 19 (67.9%) reported subjective vision improvement. This subjective improvement was significantly associated with the presence of dysmorphopsia at baseline. Logarithm of the minimal angle of resolution visual acuity improved from 0.15 (Snellen equivalent of 20/28) to 0.09 (20/25) between baseline and 3 months after PDT (P = 0.008). Older age and increased RPED height were independent risk factors of poor resolution of RPED after PDT. The mean follow-up period after treatment was 10.4 ± 13.6 months; recurrence of RPED did not occur in any case. CONCLUSION: Subfoveal RPED in central serous chorioretinopathy responded well to reduced-fluence PDT, especially in younger patients with less RPED. Dysmorphopsia, rather than decreased visual acuity, is a main symptomatic presentation in subfoveal RPED.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Hwang S, Kang SW, Kim SJ, et al. PHOTODYNAMIC THERAPY FOR SYMPTOMATIC SUBFOVEAL RETINAL PIGMENT EPITHELIAL DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: Outcomes and Prognostic Factors. Retina. 2019. PMID: 29517581. doi:10.1097/IAE.0000000000002108

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。